Who are Windtree Therapeutics, Inc.'s main suppliers?

Windtree Therapeutics, Inc. (WINT) key suppliers include: VARIAN-BIOPHARMACEUTICALS-INC, Evofem Biosciences, Inc., Evofem Biosciences, Inc., ORANY, ORANY and 1 more. View the full supplier network at chainsifter.com/chain/WINT.

Who are Windtree Therapeutics, Inc.'s major customers?

Windtree Therapeutics, Inc. (WINT) key customers include: Evofem Biosciences, Inc., Evofem Biosciences, Inc., SEVEN-KNOTS-LLC, ORANY, ORANY and 6 more. View the full customer network at chainsifter.com/chain/WINT.

What sector is Windtree Therapeutics, Inc. in?

Windtree Therapeutics, Inc. (WINT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Windtree Therapeutics, Inc. Supplier List (WINT): 6 Verified Suppliers

6Suppliers

11Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Windtree Therapeutics, Inc. (WINT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships

2Distinct source URLs

7High confidence

0.754Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Windtree Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
VARIAN-BIOPHARMACEUTICALS-INC	VARIAN-BIOPHARMACEUTICALS-INC	92%	Pursuant to the Asset Purchase Agreement, we purchased all of the assets of Varian’s business associated with a license agreement...
EVFM	Evofem Biosciences, Inc.	72%	Reciprocal relationship from EVFM graph: ial in each of the three months ended March 31, 2026 and 2025. As of March 31, 2026, $ 0.1 million and $ 1.1 million for the future payments that could become…
EVFM	Evofem Biosciences, Inc.	72%	rsuant to the terms of the warrant agreement, the exercise price of the July 2024 Warrants originally issued in connection with the Series C Preferred Stock was reduced to $ effective January 24, 202…
ORANY	ORANY	72%	Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended to facilitate and expedite development and review of a New Drug Application, or NDA…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended …
WINTW	WINDTREE THERAPEUTICS INC C/WTS	72%	Reciprocal relationship from WINTW graph: . The accompanying condensed consolidated financial statements reflect the 1 -for- 18 reverse split of our common stock that was approved by our Board of Dir…

Windtree Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
EVFM	Evofem Biosciences, Inc.	90%	we will act as the supplier to Evofem of its Phexxi® product outside of the United States
EVFM	Evofem Biosciences, Inc.	90%	Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: Reciprocal relationship from EVFM g…
SEVEN-KNOTS-LLC	SEVEN-KNOTS-LLC	90%	we may sell shares of common stock to Seven Knots from time to time
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended …
ORANY	ORANY	72%	Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended to facilitate and expedite development and review of a New Drug Application, or NDA…
ACUTE-THERAPEUTICS-INC	ACUTE-THERAPEUTICS-INC	62%	. The accompanying condensed consolidated financial statements reflect the 1 -for- 18 reverse split of our common stock that was approved by our Board of Directors and stockholders and made effective…
CVIE-INVESTMENTS-LIMITED	CVIE-INVESTMENTS-LIMITED	62%	. The accompanying condensed consolidated financial statements reflect the 1 -for- 18 reverse split of our common stock that was approved by our Board of Directors and stockholders and made effective…
CVIE-THERAPEUTICS-LIMITED	CVIE-THERAPEUTICS-LIMITED	62%	30, 2025 . The fair value of the June 2025 Warrants on the dates of issuance was $2.9 million. The June 2025 Warrants are considered permanent equity and do not need to be remeasured. Given the fair …
DEERFIELD-MANAGEMENT-COMPANY	DEERFIELD-MANAGEMENT-COMPANY	62%	30, 2025 . The fair value of the June 2025 Warrants on the dates of issuance was $2.9 million. The June 2025 Warrants are considered permanent equity and do not need to be remeasured. Given the fair …
DISCOVERY-LABORATORIES-INC	DISCOVERY-LABORATORIES-INC	62%	. The accompanying condensed consolidated financial statements reflect the 1 -for- 18 reverse split of our common stock that was approved by our Board of Directors and stockholders and made effective…
WINT-REAL-ESTATE-LLC	WINT-REAL-ESTATE-LLC	62%	. The accompanying condensed consolidated financial statements reflect the 1 -for- 18 reverse split of our common stock that was approved by our Board of Directors and stockholders and made effective…

Windtree Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
WINT-DEBT-13569	Warrants outstanding: 6	90%	xbrl warrant detail from xbrl 2024-12-31.
WINT-DEBT-13570	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
WINT-DEBT	Debt stack $25.0M	90%	Market cache reports total debt of $25.0M.

Windtree Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Windtree Therapeutics, Inc..

Windtree Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Windtree Therapeutics, Inc..

Windtree Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
EVFM	Evofem Biosciences, Inc.	100.00	1	['customer', 'supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AMZE	Amaze Holdings, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
CORT	Corcept Therapeutics Incorporated	50.00	2
BSBK	Bogota Financial Corp.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2

Windtree Therapeutics, Inc. Supply Chain